Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer

There is limited data on the clinical and biological parameters that enable the prediction of the benefits derived from additional chemotherapy after disease progression compared with standard chemotherapy in patients with metastatic colorectal cancer (mCRC). The present study evaluated the role of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Kim, Ka-Rham, Yoon, Jung-Hwan, Shim, Hyun-Jeong, Hwang, Jun-Eul, Bae, Woo-Kyun, Chung, Ik-Joo, Kim, Hee-Nam, Shin, Min-Ho, Cho, Sang-Hee
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2017
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530182/
https://ncbi.nlm.nih.gov/pubmed/28781687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6414
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares